Stardust Power Inc (SDST) (Q2 2026) Earnings Call Highlights: Advancing Muskogee Refinery

Stardust Power Inc (SDST) reported Q2 2026 results on an earnings call, with a Q2 net loss of $3.9 million versus $3.7 million a year earlier. CEO Roshan Pujari said Muskogee lithium refinery construction financing remains the top priority, with geotechnical investigations and permits supporting EPC readiness. The company was selected as an industrial partner in a DOE-funded Ohio University research effort. Cash used in operating activities was $4.0 million for six months.

Original reporting
Published Aug 14, 2026, 5:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 5:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stardust Power Inc (SDST) (Q2 2026) Earnings Call Highlights: Advancing Muskogee Refinery — source image
Decision brief

The 30-second read

$SDSTNeutralMed
01

Why it matters

The disclosures update traders on quarterly losses, cash usage, and incremental technical work (geotechnical/subsurface investigations) plus a DOE-funded research partnership. The biggest actionable swing factor is whether financing milestones progress beyond “active discussions,” and whether Nasdaq listing requirements are resolved.

02

Market read

Fresh quarterly financials and incremental project/partner updates may affect valuation expectations, but the lack of concrete financing breakthroughs and ongoing Nasdaq compliance evaluation keep near-term risk elevated.

03

What to watch

Nasdaq listing alternatives and warrant-related fair value dynamics could dominate near-term risk perception more than project engineering milestones.

Relevance 6/10Novelty 6/10Timing: post-market earnings call highlights, published pre-market Aug 14

Background

Stardust Power’s Q2 2026 earnings call focused on advancing its Muskogee lithium refinery toward EPC readiness while relying on ongoing financing discussions.

Company-level read

Ticker impact

$SDSTNeutralMedium confidence
Context

Stardust Power reported Q2 2026 net loss of $3.9M and disclosed ongoing Muskogee refinery financing efforts plus DOE/Ohio University selection.

Expected impact

Near-term trading likely hinges on financing progress and any Nasdaq listing resolution; absent new funding, reaction may be muted.

Evidence & confidence

The article provides fresh quarterly financials (loss, cash burn) and incremental project/partner updates, but no definitive financing close or listing outcome.

Market effects

Highlights continued critical-minerals and lithium-extraction R&D collaboration tied to domestic supply-chain policy, but with limited immediate read-through to public peers.

Muskogee refinery development narrative may support regional sentiment around Oklahoma critical-minerals investment, though no direct public-market linkage is provided.

Reiterates long-term lithium supply-chain focus; no new global pricing or trade policy data is disclosed.

Counterpoint

Despite DOE/academic partnership and site work, the absence of “material developments” on financing suggests the market may discount progress until capital is actually secured.

Key entities

  • Stardust Power Inc

    Subject of the earnings call, advancing the Muskogee lithium refinery and addressing Nasdaq listing requirements.

  • Muskogee lithium refinery

    Company’s lithium refinery project in Muskogee, positioned for EPC as commercial and financing milestones are achieved.

  • U.S. Department of Energy

    Funded research initiative where Stardust Power was selected as the industrial partner led by Ohio University.

  • Ohio University

    Leads the DOE-funded research initiative on next-generation lithium extraction technologies with Stardust Power as industrial partner.

Related articles

$SDSTMed

Stardust Power signs lithium supply deal with Charge CCCV

Stardust Power (NASDAQ: SDST) said it signed a non-binding Letter of Intent with battery technology firm Charge CCCV LLC (C4V) to supply battery-grade lithium carbonate from its Muskogee, Oklahoma refinery. C4V’s preliminary demand forecast calls for 3,000 MT in 2028, 10,000 MT in 2029, and 20,000 MT by 2030. Stardust noted the deal could cover much of planned output and generate billions if prices stay near current levels.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.